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Sulfite is a neurotoxin, which is detoxified by the molybdenum cofactor (Moco)-dependent 
enzyme sulfite oxidase (SOX). In humans, SOX deficiency causes the formation of the 
glutamate analog S-Sulfocysteine (SSC) resulting in a constant overstimulation of ionotropic 
glutamatergic receptors. Overstimulation leads to seizures, severe brain damage, and 
early childhood death. SOX deficiency may be caused either by a mutated sox gene or 
by mutations in one of the genes of the multi-step Moco biosynthesis pathway. While 
patients affected in the first step of Moco biosynthesis can be treated by a substitution 
therapy, no therapy is available for patients affected either in the second or third step of 
Moco biosynthesis or with isolated SOX deficiency. In the present study, we used a 
combination of behavior analysis and vital dye staining to show that SSC induces increased 
swimming, seizure-like movements, and increased cell death in the central nervous system 
of zebrafish larvae. Seizure-like movements were fully revertible upon removal of SSC or 
could be alleviated by a glutamatergic receptor antagonist. We conclude that in zebrafish 
SSC can chemically induce phenotypic characteristics comparable to the disease condition 
of human patients lacking SOX activity.
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INTRODUCTION
Molybdenum (Mo) is an essential element for life (Mendel, 2013), which for biological activity 
requires being complexed within the molybdenum cofactor (Moco). Eukaryotic Moco synthesis is 
a multi-step pathway that ultimately combines the pterin part of the cofactor with molybdate 
(Mendel and Kruse, 2012). Moco is found in the active site of all eukaryotic molybdenum-dependent 
enzymes (Mo-enzymes) and hence defects in any of the genes involved in Moco biosynthesis result 
in the pleiotropic loss of all Mo-enzyme activities (Mendel, 2013). The corresponding human 
disease is termed as Moco deficiency [MoCD; (Johnson and Duran, 2001)]. The Mo-enzyme sulfite 
oxidase (SOX) is vitally important for humans (Kisker et  al., 1997; Johnson and Duran, 2001; 
Schwahn et  al., 2015). Without SOX activity, the degradation of sulfur (S)-containing amino acids 
is impaired (Kisker et  al., 1997), and toxic sulfite is not detoxified. Sulfite reacts with cystin, thus 
forming S-Sulfocysteine (SSC). SSC is structurally highly similar to the excitatory neurotransmitter 
glutamate (Schwarz, 2016) and binds to glutamatergic receptors with a Ki of 2.1  μM in vitro 
(Olverman et  al., 1984). Recently, SSC was shown to stimulate glutamatergic receptors in cell 
culture (Kumar et al., 2017). SSC is highly abundant in MoCD and isolated SOX deficiency patients 
(Schwarz, 2016). Here, it causes neuronal hyperexcitation resulting in severe seizures in newborns, 
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neuronal cell death, and finally lethal brain damage (Johnson and 
Duran, 2001; Schwahn et  al., 2015). Interestingly, MoCD and 
isolated SOX deficiency can be  diagnosed immediately after birth 
by a urine test for SSC (Belaidi et  al., 2012). Hence, there is a 
therapeutic window for reverting disease conditions. Until today, 
only one MoCD therapy method exists (Schwahn et  al., 2015; 
Schwarz, 2016), which is exclusively suitable for patients harboring 
defects in the first Moco biosynthesis pathway step (MoCD Type 
A). However, no therapy is available for patients suffering under 
either MoCD caused by mutations affecting the second or third 
step of the Moco biosynthesis pathway (MoCD Types B and C) 
or isolated SOX deficiency (Johnson and Duran, 2001). Development 
of a suitable therapy for the general lack of SOX activity is hence 
of the highest importance. Murine model systems for MoCD 
Types A (Lee et  al., 2002) and B (Jakubiczka-Smorag et  al., 2016) 
are available; however, the low number of progeny and also ethical 
concerns preclude their use in systematic drug screening addressing 
the SSC-induced phenotype in MoCD or isolated SOX deficiency 
patients. Severe seizures are the most prominent phenotype of 
MoCD (Schwahn et  al., 2015). Zebrafish larvae possess the brain 
structures necessary to display seizure-like behavior (Baraban et al., 
2005). Therefore, it seems reasonable to test zebrafish as a model 
for MoCD and isolated SOX deficiency. Zebrafish produces up 
to 300 eggs per week; the embryos and larvae display a rapid 
ex utero development and are generally permeable to small water-
soluble compounds, making zebrafish accessible for high-throughput 
screening. In this study, we  present a SSC-induced phenotypic 
model for MoCD and isolated SOX deficiency in zebrafish.
MATERIALS AND METHODS
Zebrafish Strains and Husbandry
Zebrafish wild-type strain AB was used for all experiments. 
All animals were maintained according to standard procedures 
(Westerfield, 1995) and in accordance with legal regulations 
(EU-Directive 2010/63), the local authorities, the animal welfare 
representative of the Braunschweig University of Technology, 
and the Lower Saxony State Office of Consumer Protection 
and Food Safety (LAVES, Oldenburg, Germany; Az. §4 (02.05) 
TSchB TU BS).
Compounds
SSC (Sigma Aldrich) was dissolved at a concentration of 50 mM 
in distilled water. MK801 (Sigma Aldrich) was dissolved at a 
concentration of 10  mM in distilled water.
Toxicity Tests
To determine the median lethal concentration of SSC, 20 one- 
or two-cell embryos were transferred into fresh 30% Danieau 
medium (290  mM NaCl, 7  mM KCl, 4  mM MgSO4, 6  mM 
Ca(NO3)2, 50  mM HEPES buffer, pH  =  6.8) and used directly 
or raised until 24, 55, or 72  hours post fertilization (hpf). 
The medium was changed daily. For SSC treatment, the medium 
was removed and replaced by different concentrations of SSC 
in 30% Danieau reaching from 0 to 4  mM. Embryos and 
larvae were analyzed for 24  h.
Acridine Orange (AO) Staining
Upon SSC treatment, 3 days post fertilization (dpf) larvae were 
washed 3× with 30% Danieau. Staining was carried out with 
10 μg/mL AO (Sigma Aldrich) in 30% Danieau for 1  h in the 
dark at room temperature. Prior to imaging, larvae were washed 
3× with 30% Danieau. Larvae were anesthetized with 0.04% 
tricaine mesylate (Sigma Aldrich) in 30% Danieau and embedded 
in 1.5% low melting agarose dissolved in 30% Danieau.
Behavioral Experiments
About 3 dpf larvae were exposed to SSC. Mobility of all larvae 
used for tracking experiments was previously verified. For each 
experiment, five larvae per well were transferred into fresh 30% 
Danieau and allowed to habituate 10 min prior to SSC application. 
SSC was added to a final concentration of 2  mM, and the larvae 
were allowed to accommodate for 30  s. SSC was either applied 
alone or in combination with 2  mM MK801. For the control, 
an equivolume of 30% Danieau was applied. To analyze the effect 
of SSC, the motor behavior was monitored using the Samsung 
Galaxy A3 Smartphone camera with a resolution of 13 megapixel 
at 30 frames per s adapted to a stereo microscope (LEICA S8APO) 
utilizing the DKA5 Smartphone adapter (recording time: 9  min). 
Tracking experiments were performed in self-made agarose well 
plates (1.5% agarose in 30% Danieau heated and solidified and 
stamped out wells of 16 mm in diameter). To track the movement, 
movies were analyzed framewise using the Manual Tracking plugin 
of ImageJ (Schindelin et  al., 2012). Measuring points were placed 
between the eye balls of the analyzed larva. X/Y coordinates were 
used to analyze and quantify the motor behavior. The traveled 
distance between frames was calculated by using the difference 
in X/Y positions between the frames, and the percentage of time 
spent with movement was determined with calculating the amount 
of frames, where the distance traveled was >0. Statistical analysis 
was carried out using a one-tailed unpaired t test.
Inactivation of Sensory Hair Cells
Inactivation of sensory hair cells of the lateral line (Harris 
et al., 2003) was carried out by treatment with 400 μM neomycin 
in 30% Danieau for 1  h and subsequent washing 3× in 30% 
Danieau. Ablated cells were confirmed by staining with 0.05% 
DASPEI in 30% Danieau for 15  min.
RESULTS
SSC Induces Seizure-Like Behavior  
and Neurodegeneration in Zebrafish
To test for the effect of SSC on zebrafish motor behavior, 
we  applied 2  mM SSC to 3 dpf larvae and monitored the 
acute effects. SSC-treated larvae showed an increase in general 
swimming activity accompanied by circling and convulsive 
episodes (Figure 1A). We quantified these seizure-like behaviors 
(Baraban et al., 2005): SSC-treated larvae traveled a significantly 
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FIGURE 1 | Analysis of S-Sulfocysteine induced movement in 3 dpf zebrafish larvae. (A) For each experiment, routinely five larvae per well were transferred in fresh 
30% Danieau and allowed to habituate 10 min prior to S-Sulfocysteine (SSC) application. SSC was added to a final concentration of 2 mM (right, II). As a control 
(left, I), an equivolume of 30% Danieau was added. Larvae were allowed to accommodate for 30 s and then imaged for 9 min. The recorded tracks for each of the  
larvae analyzed are shown in different colors. The starting points of non-treated larvae are illustrated by asterisks with the corresponding numbers of the larvae. 
(B–D) Seizure-like behavior of SSC-treated larvae was quantified as described (Baraban et al., 2005). (B) For stage I, the total distances traveled for all larvae  
were determined and plotted. (C) Percentage time larvae spent with movement over the time span of the experiment. In an additional experiment, larvae were 
transferred to fresh medium after 10 min incubation with SSC. All data obtained for the transfer experiment were summarized in one bar chart. Error bars indicate 
the standard error of the mean. (D) Percentage of larvae showing increased activity (stage I), circling swim behavior (stage II), and clonus-like convulsions (stage III). 
For all experiments, three full independent biological replicates (rep.) were analyzed; *, significant with p < 0.01.
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FIGURE 2 | An N-methyl-d-aspartate (NMDA) receptor antagonist partially rescues the S-Sulfocysteine induced seizure-like behavior in zebrafish. (A) Glutamate 
and S-Sulfocysteine (SSC) are structurally highly similar (Schwarz, 2016). (B–E) The effect of the NMDA receptor antagonist MK801 on SSC-induced zebrafish 
movement was characterized by the addition of 2 mM MK801 to 2 and 3 dpf larvae treated with 2 mM SSC. (B) and (C) The total distance traveled by SSC-treated 
2 dpf and 3 dpf larvae was determined and compared to the distance traveled in the presence of SSC + MK801. As controls, larvae were treated with MK801 and 
water, respectively. (D) and (E) Percentage of time SSC-treated and SSC + MK801-treated larvae spent with movement. The controls were the same as for (B) and 
(C). Three full independent biological replicates were analyzed. Error bars represent the standard error of the mean. NS, not significant; *, significant with p < 0.01.
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longer distance and spent more time with movement as 
non-treated larvae (Figures  1B,C), hence conforming to “stage 
I: dramatically increased swim activity.” Also “stage II: rapid 
‘whirlpool-like’ circling” and “stage III: brief clonus-like 
convulsions” were drastically enhanced (Figure 1D). These 
effects were reversible as demonstrated by the normalized 
swimming behavior of SSC-treated larvae, which were transferred 
back to SSC-free medium (Figures 1B,C). To exclude effects 
of SSC on the peripheral nervous system via the sensory hair 
cells of the lateral line, we  ablated these cells; successful hair 
cell ablation was confirmed by DASPEI staining [Supplementary 
Figure S1; (Harris et  al., 2003)]. These larvae likewise showed 
a seizure-like phenotype when 2  mM SSC was applied 
(Supplementary Video S1) with the corresponding control 
showed no increased movements (Supplementary Video S2). 
These findings indicate that the observed seizure-like behaviors 
are likely caused by an SSC-induced stimulation of the central 
nervous system. To characterize the observed movements in 
detail, representative continuous frames were analyzed 
(Supplementary Figures S2,S3) with an extract of the image 
sequence of SSC-treated and non-treated larvae being shown 
in Supplementary Figure S4. Notably are episodes of involuntary 
erratic movements with aberrant bending of the body axis 
differentiating the SSC-induced phenotype from the sine-like 
curved axis during movement of control larvae. Prolonged 
exposure of larvae to SSC is lethal with the SSC LC50 values 
varying depending on developmental stages (Supplementary 
Figure S5). Consistently, increasing levels of cell death in the 
central nervous system were observable in larvae upon prolonged 
incubation with SSC (Supplementary Figure S6A). Here, the 
heads of SSC-treated zebrafish larvae were also found to engorge 
(Supplementary Figures S6A,B), which might correspond to 
cerebral edema and increased brain pressure in MoCD patients 
(Durmaz and Özbakir, 2018).
An N-Methyl-d-Aspartate (NMDA) 
Receptor Antagonist Partially 
Compensates SSC-Triggered  
Movements in Zebrafish Larvae
The NMDA receptor antagonist MK801 was found to partially 
compensate for excitotoxicity caused by the glutamate analog 
SSC (Figure 2A) in mammalian cell culture and mice (Kumar 
et  al., 2017). To test for NMDA receptor antagonist efficacy 
in SSC-treated zebrafish, we applied the non-competitive NMDA 
receptor antagonist MK801 to 2 and 3 dpf larvae. Upon 
application to 2 dpf larvae, the afore described seizure-like 
behavior (Figure 1) was largely compensated as documented 
by normalized larval movement (Figures 2B,D), reduced clonus-
like convulsions, and diminished circling behavior. Therefore, 
MK801 can partially compensate the SSC-triggered movements. 
When 3 dpf larvae were co-treated, the compensation of the 
SSC-induced phenotype was less pronounced and not significant 
(p = 0.1004, Figure 2C; p = 0.256, Figure 2E), probably because 
of diminished MK801 penetrance into the brain with ongoing 
larval differentiation. Nevertheless, these findings in conjunction 
with the well-known binding and the activation of mammalian 
NMDA receptors by SSC (Olverman et  al., 1984; Kumar et  al., 
2017) suggest that SSC-mediated hyperactivation of NMDA 
receptors is conserved in zebrafish.
DISCUSSION
In this study, we  describe the effect of SSC on zebrafish 
larvae. SSC-treated larvae were found to display all qualitative 
and quantitative characteristics defined for seizure-like behavior 
(Baraban et al., 2005) as demonstrated by visual and statistical 
evaluations, hence leading us to the conclusion that SSC can 
be  used to chemically induce a highly reproducible and 
therefore robust phenotypic model for MoCD and isolated 
SOX deficiency in zebrafish. Prior to this, the effects of excessive 
SSC in the central nervous system and other tissues of 
vertebrates were studied directly in the patients suffering from 
MoCD or isolated SOX deficiency or in mice carrying loss-
of-function mutations in the respective genes (Johnson and 
Duran, 2001; Lee et  al., 2002; Belaidi et  al., 2012; Jakubiczka-
Smorag et  al., 2016; Schwarz, 2016; Durmaz and Özbakir, 
2018). As reported for murine cell culture (Kumar et  al., 
2017), high SSC concentrations have a toxic effect on zebrafish 
larvae. Moreover, SSC LC50 values were found to vary, depending 
on the developmental stage, suggesting a development-related 
sensitivity. Interestingly, prolonged exposure to SSC results 
in massive cell death in the central nervous system and also 
possibly in cerebral edema, which is well known for patients 
suffering from MoCD (Durmaz and Özbakir, 2018). Therefore, 
the phenotypic effects of MoCD and isolated SOX deficiency 
can now be  studied in a concentration and development-
related manner. The effects of SSC on zebrafish larvae can 
be  partially rescued by the application of the non-competitive 
NMDA receptor antagonist MK801. The compensatory potential 
of MK801 is at most in 2 dpf larvae, and its reduced 
compensatory potential for 3 dpf larvae may be best explained 
by lowered permeability at that developmental stage. Also, 
blood-brain barrier differentiation or a diverging subunit 
composition of zebrafish NMDA receptors at different 
developmental stages may be  causal (Fleming et  al., 2013; 
Meneszes et  al., 2015). A compensatory effect of MK801 was 
already described for SSC-treated mouse neurons in culture 
(Kumar et  al., 2017). These findings suggest that in zebrafish, 
the underlying principles of SSC-triggered excitotoxicity may 
be related to the respective processes in mammals. Furthermore, 
these results show that zebrafish larvae may be used to screen 
for compounds to rescue or alleviate the SSC-induced effect 
with anti-seizure or anti-epileptic drugs being most obvious. 
Such screenings have been already successfully performed with 
a chemical-induced zebrafish model with a focus on the 
inhibitory neurotransmitter gamma-aminobutyric acid (Baraban 
et  al., 2005; Afrikanova et  al., 2013). Using zebrafish as a 
model system to study the effects of SSC neurotoxicity paves 
the way for the systematic characterization of SSC-related 
effects on the developing vertebrate nervous system. The value 
of such chemical-induced disease models for not only 
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fundamental research but also drug development is long known 
with Morbus Parkinson being a prominent example (Hisahara 
and Shimohama, 2011). Not only various already developed 
therapeutics but also pre-clinical substances may be  easily 
and effectively tested with respect to their potential to 
compensate SSC-induced phenotypes in zebrafish.
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SUPPLEMENTARY VIDEO S1 | Motor behavior of S-Sulfocysteine treated 
zebrafish larvae with previously ablated hair cells. In 3 dpf zebrafish larvae, the 
sensory hair cells of the lateral line were ablated by treatment with 400 μM 
neomycin in 30 % Danieau medium for 60 min. After confirmation of the ablation 
by staining with 0.05 % DASPEI in 30 % Danieau for 15 min (Supplementary 
Figure S1), 5 larvae per well were transferred in fresh 30 % Danieau and allowed 
to habituate 10 min prior to S-Sulfocysteine (SSC) application. SSC was added to 
a final concentration of 2 mM. Three independent biological replicates were 
analyzed with a representative video of the observed phenotype being shown.
SUPPLEMENTARY VIDEO S2 | Motor behavior of zebrafish larvae with 
previously ablated hair cells. In 3 dpf zebrafish larvae, the sensory hair cells of the 
lateral line were ablated by treatment with 400 μM neomycin in 30 % Danieau 
medium for 60 min. After confirmation of the ablation by staining with 0.05 % 
DASPEI in 30 % Danieau for 15 min (Supplementary Figure S1), 5 larvae per 
well were transferred in fresh 30 % Danieau and allowed to habituate 10 min. As 
these larvae served as a control for the S-Sulfocysteine treatment carried out 
(Supplementary Video S1), an additional equivolume of 30 % Danieau was 
applied. Three independent biological replicates were analyzed with a 
representative video of the observed phenotype being shown.
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